📖

ND0612 Subcutaneous Levodopa Infusion PD Trial (NCT04006210)

wiki page Created: 2026-04-02 13:40:08 By: crosslink-migration Quality: 50% ✓ SciDEX ID: wiki-clinical-trials-nd0612-subcutaneous
Related Entities
clinical-trials-nd0612-subcutaneous-levodopa-infusion-parkinsons-nct04006210
Metadata
slugclinical-trials-nd0612-subcutaneous-levodopa-infusion-parkinsons-nct04006210
entity_typeclinical
kg_node_idNone
🌍 Provenance Graph 1 nodes, 0 edges

No provenance edges found

Linked Artifacts (26)
mentions🧪Synthetic Biology Approach: Designer Mitochondrial Export Sy90%
related🧪Synthetic Biology Approach: Designer Mitochondrial Export Sy81%
related🧫Cytochrome Therapeutics70%
related🧫Cytochrome Therapeutics70%
mentions🧪Pericyte Contractility Reset via Selective PDGFR-β Agonism60%
mentions🧪Magnetosonic-Triggered Transferrin Receptor Clustering60%
related🔬What are the mechanisms underlying blood-brain barrier trans50%
related🔬What are the mechanisms underlying perivascular spaces and g50%
related🔬What are the mechanisms underlying blood-brain barrier trans50%
related🔬What are the mechanisms underlying perivascular spaces and g50%
related🧪Synthetic Biology Rewiring via Orthogonal Receptors50%
related🧪Blood-Brain Barrier SPM Shuttle System50%
related🧪Glymphatic System-Enhanced Antibody Clearance Reversal50%
related🧪SASP-Driven Aquaporin-4 Dysregulation50%
related🧪Circadian-Gated Maresin Biosynthesis Amplification50%
related🧪Circadian Glymphatic Entrainment via Targeted Orexin Recepto50%
related🧪Aquaporin-4 Polarization Rescue50%
related🧪Circadian Glymphatic Rescue Therapy (Melatonin-focused)50%
related🧪Optogenetic Control of Mitochondrial Transfer Networks50%
mentions🧫cGAS-STING Pathway Validation Study in Parkinson's Dise40%
mentions🧫Epigenetic Dysregulation Validation in Parkinson's Dise40%
mentions🧫Multiscale Computational Modeling of Protein Aggregation Kin40%
mentions🧫Non-Motor Symptom Progression in Parkinson's Disease — 40%
mentions🧫Spinocerebellar Ataxia (SCA) Disease-Modifying Therapy Devel40%
related🧪Pericyte Contractility Reset via Selective PDGFR-β Agonism40%
related🧪Magnetosonic-Triggered Transferrin Receptor Clustering40%